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Buenos Aires, ArgentinaABSTRACT It has been suggested that above a critical protein concentration, ﬁsh Type III antifreeze protein (AFP III) self-
assembles to form micelle-like structures that may play a key role in antifreeze activity. To understand the complex activity of
AFP III, a comprehensive description of its association state and structural organization in solution is necessary. We used analyt-
ical ultracentrifugation, analytical size-exclusion chromatography, and dynamic light scattering to characterize the interactions
and homogeneity of AFP III in solution. Small-angle neutron scattering was used to determine the low-resolution structure in solu-
tion. Our results clearly show that at concentrations up to 20 mg mL1 and at temperatures of 20C, 6C, and 4C, AFP III is
monomeric in solution and adopts a structure compatible with that determined by crystallography. Surface tension measure-
ments show a propensity of AFP III to localize at the air/water interface, but this surface activity is not correlated with any aggre-
gation in the bulk. These results support the hypothesis that each AFP III molecule acts independently of the others, and that
speciﬁc intermolecular interactions between monomers are not required for binding to ice. The lack of attractive interactions
between monomers may be functionally important, allowing for more efﬁcient binding and covering of the ice surface.INTRODUCTIONAntifreeze proteins (AFPs) are characterized by their ability
to bind ice and prevent its growth and recrystallization (1,2).
The inhibition of ice growth results in a decrease of the
freezing point without changing the melting point by means
of a noncolligative mechanism (3,4). The difference between
these two temperatures, termed thermal hysteresis, is widely
used as an indicator of AFP activity (5). It allows organisms
to achieve a supercooled state of body fluids. A two-step
adsorption and growth inhibition mechanism for the interac-
tion of AFPs with ice was previously proposed (6). In this
model, AFP molecules bind to well-defined sites on the ice
surface. Ice may continue to grow through the adsorbed
AFP impurities, developing a curved growth front. The
increased surface area and curvature make an energetically
less favorable configuration and lead to termination of crystal
growth, a phenomenon known as the Kelvin effect (2,7,8).
Although AFPs have been extensively studied, the detailed
interactions by which they inhibit ice growth and recrystalli-
zation are not completely understood.
To date, five different groups of polar fish AFPs have been
described (Types I–IV and antifreeze glycoproteins) (9,10).
Each group contains several isoforms and exhibits a charac-
teristic taxonomic distribution. Our work is centered on fish
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0006-3495/10/07/0609/10 $2.00members of the subclass Zoarcoidei. AFP III has been the
subject of a large number of experimental and computational
studies (2), as well as biotechnological investigations (11).
In addition to its antifreeze activity, AFP III (like some other
AFP families) decreases the hypothermic damage in living
cells during low-temperature preservation above 0C, in
the absence of ice (12,13). The molecular mechanism behind
this protection remains unclear. The structure of AFP III has
been described by NMR (14,15) and x-ray crystallography
(16,17), and is being studied by neutron diffraction (18). It
shows a globular b-clip fold of dimensions 24 A˚  26 A˚ 
40 A˚, and exhibits a flat ice-binding surface (5,19,20).
Many proteins have a tendency to interact among them-
selves, achieving in this way their biofunctionality. To
understand the complex activities of AFP III (i.e., the inhibi-
tion of ice growth and recrystallization at subzero tempera-
tures and the protection of cold-sensitive cells from
hypothermic damage at low but above zero temperatures),
a comprehensive description of its association state and
structural organization in solution is essential.
It has been suggested that cooperative interactions
between AFP molecules on the ice surface are required for
complete inhibition of ice crystal growth. Wen and Laursen
(21) noted that for Type I AFP, which comprises a single
a-helix of 37 amino acid residues, the relationship between
the AFP concentration and the inhibition of ice growth is
biphasic. At low concentration, ice grows along both the c
and a axes to produce a crystal with a constant c/a axis ratio
of ~3.3. Above a critical AFP concentration, the ice crystaldoi: 10.1016/j.bpj.2010.04.030
610 Salvay et al.stops growing and thermal hysteresis is observed. The
authors proposed that AFP binding is reversible at low
concentrations because the individual interactions between
an AFP molecule and ice are weak (22). At high concentra-
tions, the AFPmolecules begin to bind cooperatively through
side-by-side interpeptide hydrophobic interactions (22).
A comparable bimodal relationship between the protein
concentration and the inhibition of ice growth has been
observed in globular AFP III (23). To test the need for coop-
erativity in AFP III binding, DeLuca and co-workers (24)
constructed AFP-fusion proteins with an overall diameter
far exceeding that of AFP III to prevent interpeptide interac-
tions. The fusion proteins did not suffer any loss of thermal
hysteresis activity and were generally more active than the
free AFP. These results are consistent with a model in which
AFP molecules bind independently to ice.
In contrast, Du et al. (25–27) suggested that specific inter-
actions between AFP III proteins are required for binding to
ice, and that the self-assembly of AFP III on the surface of
ice may be expected. Observing that the surface of AFP III
presents hydrophilic and hydrophobic regions, and based
on ice nucleation, surface tension, and dynamic light scat-
tering (DLS) studies, they proposed that above a critical
protein concentration value (2.5 mg/mL), the amphipathic
AFP III self-assembles into micelle-like structures; more-
over, they suggested that these aggregation properties could
play a key role in antifreeze activity (25–27).
We recently studied the electro-optical properties of AFP
III in solution (28). We found that the concentration depen-
dence of the electrical properties exhibited nonideal behavior.
These results could conceivably support the protein aggrega-
tion hypothesis, but may also be explained by the existence of
some other types of intermolecular interactions. In the work
presented here, our goal was to directly investigate the asso-
ciation state, interactions, and solution structure of AFP III.
Such information is a prerequisite for understanding the
activity of AFP III and clarifying whether AFP III molecules
act independently or specific interactions between monomers
are required for cooperative binding to ice.
We used analytical ultracentrifugation (AUC), which
combines particle separation and analysis into a powerful
technique for characterizing sample homogeneity and rigor-
ously determining the protein size, mass, and interactions
(29). Analytical size-exclusion chromatography (SEC)
coupled to multi-angle laser light scattering (MALLS), and
DLS were also applied to confirm the AUC results in the
absence of a centrifugal field. Small-angle neutron scattering
(SANS), a key technique for determining the low-resolution
structure of macromolecules in solution (30), was used to
compare the known crystallographic structure with the struc-
ture in solution. The surface activity properties of AFP III at
the air/water interface were also studied.
Our results clearly show that AFP III at concentrations up
to 20 mg mL1 is monomeric in solution, at 20C, 6C, and
4C, and adopts a structure compatible with the crystallo-Biophysical Journal 99(2) 609–618graphic structure. Surface tension measurements show
a propensity of AFP III to localize at the air/water interface,
but this surface activity is not correlated with any aggrega-
tion of the protein in the bulk. These data are essential for
elucidating how AFP III functions.MATERIALS AND METHODS
The HPLC-12 isoform from ocean pout (Macrozoarces americanus) AFP
III, corresponding to the protein sequence code P19614 and the 1HG7
PDB high-resolution structure (20), was overexpressed in Escherichia coli
as inclusion bodies, solubilized in 2 M urea, and purified as described previ-
ously (28). The purified protein was dialyzed twice against distilled and
deionized water and lyophilized. Solutions of AFP III at different concentra-
tions were prepared by dissolution of the same lyophilized protein batch in
H2O and D2O, or in 150 mM NaCl, 20 mM Tris-HCl buffer at pH 7.5
(Solvent A). We chose to use pure and deionized water (either H2O and
D2O) because other studies on the same protein were performed under iden-
tical conditions (25–27). The chemical purity of the sample was checked by
Tris/tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis and
mass spectrometry with a molecular mass of 7034 Da (see Fig. S1 in the
Supporting Material). The molar extinction coefficient at 280 nm was exper-
imentally obtained as 1568 5 33 M1cm1 (E0.1% ¼ 0.223 5 0.005 mg
mL1cm1; see Supporting Material). To check the proper folding of our
protein in pure H2O, we measured the far and near ultraviolet circular
dichroism (CD) spectra between 180 and 260 nm, and 250 and 340 nm,
respectively (Fig. S2). The spectra resembled those obtained for AFP III
in different solvents (28). Additionally, this lyophilized protein batch was
successfully used in crystallization experiments. AFP III was shown to be
stable in H2O and D2O at 4
C, 6C, and 20C (28). The partial specific
volume v of AFP III is required for the interpretation of SANS and/or
AUC experiments, and v ¼ 0.758 5 0.005 mL g1 was determined from
precise density measurements (see Fig. S3). The experimental values of
molar mass, molar extinction coefficient at 280 nm, and v are very close
to those obtained from the amino acid content.Experimental methods
Sedimentation velocity (SV) experiments were performed at 20C in H2O
and D2O, and at 4
C in Solvent A for AFP III samples at concentrations typi-
cally between 0.5 and 20 mg mL1. Sedimentation equilibrium (SE) exper-
iments were performed at 4C in Solvent A for AFP III samples between 0.5
and 10 mg mL1. The sedimentation depends on the sedimentation and
diffusion coefficients, s and D, of the macromolecules in solution and their
interactions; s and D are related to the macromolecular molar mass, M,
which can also be obtained directly from the SE. The Supporting Material
gives details on the SV and SE experiments, all programs used for the anal-
ysis, the theoretical background, and principles of the analysis.
Analytical SEC combined with MALLS, DLS, and surface tension exper-
iments are also described in the Supporting Material.
SANS experiments were carried out at 6C on the D22 small-angle
diffractometer at the Institut Laue-Langevin (Grenoble, France). See the
Supporting Material for details regarding the experiments, analysis, and
programs used for the analysis.RESULTS
Sedimentation velocity of AFP III: general
behavior
The homogeneity of themolecular mass and size of AFP III in
solution between 0.5 and 20 mg mL1 was measured using
AUC SV. Experiments were done in Solvent A at 4C, as
FIGURE 1 SV of AFP III at 60,000 rpm and 4C
in 20 mM Tris-HCl, 150 mM NaCl, pH 7.5. (A)
Selection of raw data for AFP III at 5.1 mg
mL1. (B) Superposition of experimental (dots)
and fitted (continuous line) profiles corrected for
all systematic noise for AFP III at 5.1 mg mL1.
The last profiles correspond to 20 h of sedimenta-
tion. The fit was obtained from the c(s) analysis
with the program SEDFIT. (C) Superposition of
the differences between the experimental and fitted
curves. (D) Corresponding c(s) distribution in the
range of 0.1–15 S. (E) Superposition of the c(s)
distributions for different concentrations of AFP
III in the range of 0.4–0.9 S, corresponding
to >96% of the total signal. The concentrations
are 0.51, 1.0, 5.1, 10.2, 15.2, and 20.3 mg mL1.
For clarity, the interference signal is multiplied by
a factor of 4 for the experiments performed in
0.3 cm optical path centerpieces, for concentrations
higher than 10 mg mL1. Concentrations 0.51 and
1.0 mg mL1 are not visible in the figure because of
the low signal in comparison with the high concen-
trations.
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C, in view of the SANS exper-
iments. Sedimentation of AFP III displays a well-defined
boundary in Solvent A (Fig. 1), as well as in D2O (profiles
not shown) and in H2O (Fig. S4). AFP III sediments more
slowly in D2O than in H2O, and at 4
C compared to 20C,
which is expected because of the larger density (in D2O)
and viscosity (in D2O or at 4
C) of the solvent.
Enhanced van Holde-Weischet analysis of the SV
of AFP III
We used the van Holde-Weischet analysis (31) for a qualita-
tive evaluation of heterogeneity and interaction. Fig. S5
compares the van Holde-Weischet plots obtained for AFP
III between 5 and 20 mg mL1 at 42,000 rpm and 20C in
H2O, and at 60,000 rpm and 4
C in Solvent A. For all
concentrations and experimental conditions, the extrapola-
tions to infinite time (intercepts) show one well-defined
group of s20,w values around 1 S, indicating the absence of
aggregates. The large diffusion of AFP III limits the scope
of the analysis and at least partly explains the limited
scattering of the intercepts at 42,000 rpm compared to
60,000 rpm. At 60,000 rpm, it is clear that increasing the
AFP III concentration makes the extrapolated values of
s20,w decrease from slightly above to slightly below 1 S, indi-
cating nonideality. In addition, the convergence of the lines
is shifted to the right with increasing concentration, which is
further evidence of the expected nonideality effects. The
origin of the asymmetry of the plot close to the intercept is
not clear. Clearly, however, AFP III samples appear homo-
geneous with no evidence of association equilibrium.Size distribution analysis of the SV of AFP III
Sedimentation profiles were then analyzed in terms of
a distribution of ideal particles using the c(s) analysis
(32). The c(s) method deconvolutes the effects of diffusion
broadening, which results in high-resolution sedimentation
coefficient distributions. The superposition of the experi-
mental and modeled sedimentation profiles for AFP III in
Solvent A at 5.1 mg mL1 are shown in Fig. 1 B. The resid-
uals are only imperfectly randomly distributed around zero
(Fig. 1 C), which is reasonably related to the nonideality of
the concentrated solutions. However, the maximum residual
is <1% of the total number of interference fringes (here,
0.1/17 fringes) for all tested concentrations, which is not
bad. The c(s) analysis in the range of 0.1–15 S shows one
major, well-defined peak (96% of the total signal) at
0.59 S (Fig. 1 D). Fig. 1 E shows the superposition of
c(s) curves, built in the range of 0.5–0.9 S, for AFP III in
Solvent A and 4C at different concentrations between
0.51 and 20.3 mg mL1. For all of the samples, a single
contribution representing 96–99% of the total signal is
observed at z0.6 S. The s-value slightly decreases with
increasing protein concentration, indicating nonideality.
Experiments performed in D2O and H2O at 20
C, at protein
concentrations in the same range, similarly show only one
main species—at z0.5 S and 1.0 S, respectively—corre-
sponding to 98–99% and 97–99%, respectively, of the total
signal (data not shown and Fig. S4, respectively). Thus, the
AFP III samples are essentially homogeneous and there is
no evidence of concentration-dependent association or
aggregation.Biophysical Journal 99(2) 609–618
612 Salvay et al.Noninteracting species model analysis of the SV
of AFP III and nonideal sedimentation
The SV profiles of AFP III were analyzed in terms of inde-
pendent noninteracting species. The relevance of large
species attributed to aggregates is negligible because when
the data are analyzed in terms of two species (monomer
and aggregates), the program converges for all concentra-
tions to the model of a single species. The species is charac-
terized by a number of interference fringes, J, proportional to
concentration; a sedimentation coefficient, s; and an apparent
diffusion coefficient, Dapp. J and s from the c(s) analysis are
(within experimental error) those of the noninteracting
species model. We note that J for AFP III in H2O, D2O,
and Solvent A is perfectly linearly related to the total concen-
tration c (see Fig. S6). The slope of the linear regression
gives the value of the refractive index increment vn/vc ¼
0.189 5 0.003 mL g1, which agrees with the standard
value of 0.186 mL g1 tabulated for soluble and globular
proteins. This indicates that the estimate of J is precise,
and the total protein concentration and the concentration of
the single species of AFP III are equivalent, confirming
that aggregates, if they exist, can only be present in negli-
gible amounts. Linear regressions of s1(c) and Dapp(c) are
shown in Fig. S7 and results are reported in Table 1. The
slight decrease of the s-values under all solvent conditions
with increasing AFP III concentration is related to nonideal-
ity effects. The concentration-dependency factor ks is posi-
tive, which corresponds to weak repulsive interparticle
interactions related to excluded volume effects (see the Sup-
porting Material). If there were weak interactions leading to
self-association, then upon increasing c, s would increase
from the sedimentation coefficient at infinite dilution, s0,
and the related ks would be negative. The shape of the sedi-
mentation boundary is affected by the macromolecular diffu-
sion, which may change with concentration, as well as by the
concentration dependency of s (33). This means that Dapp
(calculated from an inappropriate model of a noninteracting
species) is not a diffusion coefficient except in the ideal case,
i.e., at infinite dilution. The intercept in Fig. S7 indeed repre-
sents the diffusion coefficient at infinite dilution, D0.Molecular characteristics of AFP III in solution
from the SV
The hydrodynamic radius RS and the molecular weight M of
AFP III in H2O and D2O at 20
C, and in Solvent A at 4C,TABLE 1 Concentration-dependence analysis of sedimentation of A
Tris-HCl, 150 mM NaCl, pH 7.5 (Solvent A), at 60,000 rpm and 4C
s0 (S) s0,20,w (S) ks (mL g
1) D0 (1
H2O 1.005 0.01 1.005 0.01 5.95 0.3 13
D2O 0.595 0.01 1.095 0.02 5.85 0.3 11
Solvent A 0.635 0.02 1.035 0.03 8.85 0.7 8
Errors are estimated from the linear regression analysis of data of Fig. S7 and p
Biophysical Journal 99(2) 609–618are derived from the extrapolated values to infinite dilution s0
and D0 (see Supporting Material) and given in Table 1. The
experimental value of M is in excellent agreement with that
calculated for monomeric AFP III from the amino acid
sequence or measured by mass spectrometry. The experi-
mental value of RS ¼ 1.6 nm agrees with the hydrodynamic
radius of monomeric AFP III calculated from the 1HG7 PDB
entry and using the program HYDROPRO (34). It corre-
sponds to a frictional ratio of 1.25, which is a usual value
for a compact protein. A value of 1.17 is calculated from
tabulated data for a 7 kDa native folded protein (35,36).
Thus, AFP III is a monomer of AFP III under all of the exper-
imental conditions.Sedimentation equilibrium experiments
SE experiments are a rigorous way to ascertain the molar
mass of a macromolecule in solution. Experiments were
done at 4C in Solvent A at concentrations of 0.5, 1, 2.5,
5.1, and 10.2 mL1, and at three angular velocities. Fitting
each sample separately gives molar masses decreasing
from 7.8 kDa for the lowest concentration to 6.3 kDa for
the largest one (not shown). The decrease of these values
may be related to nonideality (see Supporting Material).
However, as can be seen in Fig. 2, the simplest model of
one ideal species allows all the data to be nicely fitted. It
provides a molar mass of 7 kDa corresponding to AFP III
as a monomer.Analytical SEC with light-scattering detection
We also performed SEC experiments combined with refrac-
tometry and multi-angle light scattering (Fig. S8), which al-
lowed us to evaluate the sample homogeneity and determine,
in an absolute way, the molar mass of macromolecules and
assemblies in solution (37). The sample eluted from the
SEC column at 20C for AFP III in Solvent A as a single
peak. The single, well-defined elution peak confirms the
nonexistence of aggregates of AFP III in solution, since
light-scattering detection emphasizes the detection of the
largest species. The absolute molecular mass of the species
corresponding to the peak was determined at each point of
the chromatogram. The polydispersity factor is equal to
1.04 5 0.07, suggesting a monodisperse sample, whereas
M is 7.3 kDa, which is in excellent agreement with the
molecular mass obtained from SV experiments and further
demonstrates that AFP III is a monomer in solution.FP III in H2O and D2O at 42,000 rpm and 20
C, and in 20 mM
07cm2 s1) D0,20,w (10
7cm2 s1) M (kDa) RS (nm)
.75 0.1 13.75 0.1 7.35 0.2 1.65 0.1
.05 0.1 13.65 0.2 8.05 0.2 1.65 0.1
.05 0.2 13.55 0.3 7.75 0.4 1.65 0.1
ropagated according to the rules of errors.
FIGURE 2 Equilibrium sedimentation profiles
of AFPIII at 4C in Solvent A. Each panel shows
the superposition of the experimental equilibrium
profiles (dot) and their fit (line) (upper part) ob-
tained at 20,000 rpm (#), 32,000 rpm ($), and
50,000 rpm ({), and the superposition of the differ-
ences between the experimental and fitted curves
(lower part). All data were globally fitted using
the program Sedphat in the model of one noninter-
acting species without noise evaluation, but adjust-
ing a baseline for each cell (0.017, 0.0143,
0.002, 0.008, 0.011, and 0.021 from top
left to bottom right panels). This very simple and
constrained model provides a rather good superim-
position of the fitted and experimental profiles.
Data were considered up to A280 ¼ 1.2, i.e., to
a maximum concentration of 17 mg mL1. The
determined molecular mass is 6966 Da.
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The dependence of the size and polydispersity of AFP III
with the concentration was also investigated by means of
DLS. DLS experiments at 20C were performed for five
concentrations of AFP III ranging from 0.55 to 22.1 mg
mL1 in H2O. The autocorrelation functions were described
well by a single-exponential decay for all concentrations,
with typical baseline values of 1.001–1.002, which corre-
sponds to a monomodal or primarily monomodal distribution
without polydispersity. At 22.1 and 11.0 mg mL1, DLS
analysis revealed a 100% homogeneous sample. At the
smallest concentrations of 5.5, 2.8, and 0.55 mg mL1, small
additional contributions were detected at 51, 55, and 160 nm,
respectively, which were clearly related to dust and did not
have to be considered. The value of RS obtained for AFP III
was z1.4 nm and did not vary significantly with AFP III
concentration in the range of 0.55–22.1 mg mL1 (see
Table S1). Again, there is no indication of any association
of the protein. TheRS values obtained fromDLS are in reason-
able agreement with what was experimentally determined by
SV or calculated from the crystallographic structure.AFP III structure in solution: SANS experiments
Fig. 3 A shows the experimental scattering curves (normal-
ized to the highest concentration and scaled to one) for
AFP at the three concentrations measured at 6C, as well
as the theoretical curve calculated from PDB entry 1HG7.
In the concentration range explored, the experimental scat-
tering curves agree excellently with the theoretical curve
over the entire angular range. From our data, there is no
evidence of any higher oligomeric states. The experimental
radii of gyration (Fig. 3 B)—10.40 5 0.03, 10.33 5 0.03,and 10.28 5 0.03 A˚ (AFP III at 21.6, 16.2, and 10.8 mg
mL1)—are equally in excellent agreement with that from
the PDB structure (10.2 A˚). Minor differences may be due
to effects of hydration shell water (38). We therefore
conclude that AFP III is in a monomeric state in solution,
and there are no structural differences between the crystal
structure and the structure in solution. This is further corrob-
orated by a comparison of the back-calculated scattering
curve from an artificial AFP III dimer with the experimental
data, which are significantly different (Fig. S9).
In addition, we calculated a pair distance distribution func-
tion p(r) from the experimental data and the monomeric
1HG7 (Fig. S10). Both display a slightly asymmetric
Gaussian shape indicative of a compact particle deviating
slightly from a sphere. The minor deviations at larger
distances may be due to disordered side chains on the surface
of the protein. Fig. 3 C shows the superposition of the DAM-
MIN-created low-resolution shape and 1HG7. They are very
similar, as reflected by a low normalized spatial discrepancy
criterion of 0.74 (values< 1.0 indicate similarity; the smaller
the value, the more similar are the two structures).Surface-active properties of AFP III at the air/water
interface
The relative surface activity of AFP III was determined from
measurements of surface tension as a function of protein
concentration in H2O at 20
C. As we can see in Fig. 4,
AFP III induces a low decrease of surface tension when the
protein concentration increases. For the first experiment (stir-
ring time of 5 min), there is possibly a plateau between
2.3 and 3.7 mg mL1, and above an estimated value of
3.7 mg mL1, a break in the curve is observed and the surfaceBiophysical Journal 99(2) 609–618
FIGURE 3 SANS of AFPIII at 6C. (A) Experimental neutron scattering
curves from AFP in D2O at three concentrations and normalized to the high-
est concentration and scaled to one, as well as the theoretical one from PDB
entry 1HG7 (calculated with CRYSON). (B) Guinier plots of the same
experimental data. (C) Superposition of low-resolution structure from exper-
imental data and high-resolution PDB 1HG7 using the program SUPCOMB.
The figure was created using the program PYMOL (http://www.pymol.org).
FIGURE 4 Surface tension of AFP III in H2O at 20
C as a function of
concentration. An initial concentration of 4.8 (-) and 6 () mg mL1 was
successively diluted with a stirring time of 5 (-) and 20 () min between
each dilution and measurement.
Biophysical Journal 99(2) 609–618
614 Salvay et al.tension increases with increasing AFP III concentration up to
4.8 mg mL1. However, the evidence for these features in
Fig. 4 seems rather poor, and they could just be noise. For
this reason, we performed a second experiment from a stock
solution at 6 mg mL1, with a longer time between each
measurement.Under these conditions,we observe aminimum
value of the surface tension at 2.3 mg mL1, which is compa-
rable to that measured at 25C by Du et al. (25). This
minimum point should indicate a rearrangement of the AFP
III on the air/water interface (see below). The discrepancy
between our two curves is attributed to slow processes at
the interface reaching equilibrium.We note a feature common
to the two experiments: the value of the surface tension at the
lowest measured concentration (0.006 or 0.01 mg mL1) is
~20 mN m1 below the value of pure water.DISCUSSION
Our aim in this work was to characterize the interactions of
AFPIII in solution and the structure of the association states,
if any. In the context of a structural study, the purity and
quality of the purified recombinant protein sample used here
were checked bymeans of chemical studies, densitymeasure-
ments, and optical spectroscopy. The experimental values of
the molar extinction coefficient, partial specific volume, and
polypeptide molar mass coincide with those predicted from
the amino acid sequence of AFP III. Also, the CD spectra
were the same as those described in the literature (28). AFP
III was studied in a large range of protein concentrations,
with the largest being close to the physiological concentration
(the ocean pout, M. americanus, produces type III AFPs at
a level of ~25 mg mL1 in serum during winter (20)).AFP III is a monomer at up to 20 mg mL1
We used different but complementary experimental meth-
odologies for our purpose. AUC was used to investigate
the hydrodynamic behavior of AFP III. Analysis of SV
Fish Type III Antifreeze Protein in Solution 615experiments using numerical solutions of the Lamm equa-
tion can adequately describe the homogeneity and hydro-
dynamic behavior of complex biomolecules in solutions
(39–41). Our SV experiments clearly show that, under
all of our experimental conditions (in H2O, D2O, or
Solvent A, at 4C and 20C), AFP III was highly homoge-
neous in a large range of concentrations (from 0.5 up to
22 mg mL1). The same behavior was observed in His-
tagged AFP III (results not shown). The molecular mass
(M ¼ 7.3 kDa) and hydrodynamic radius (RS ¼ 1.6 nm)
of the single species sedimenting in the SV experiments
are very close to those predicted from the amino acid
sequence and the crystallographic structure of an AFP III
monomer, which shows a compact structure with half
dimensions of 1.2 nm  1.3 nm  2.0 nm (16,17). The
concentration dependence of the sedimentation coefficient
is the opposite of what would be expected if there were
interactions leading to association between monomers,
and can be simply related to repulsive excluded volume
effects (see Supporting Material). Complementary SE, per-
formed at 4C and in Solvent A for samples between
0.5 and 10 mg mL1, and analytical SEC performed at
20C and in Solvent A confirmed the homogeneity and
monomer state of AFP III. Liu and Du (26) reported two
sizes of molecules from DLS measurements of AFP III
in pure H2O at concentrations of 0.5 and 2.5 mg mL
1.
The smallest, with RS ¼ 0.55 nm, which the authors asso-
ciated with monomeric protein, was present at the two
AFP III concentrations, whereas the largest, with RS ¼
1.4 nm, which they related to AFP III aggregates, was
observed only at 2.5 mg mL1 and dominated the signal.
Based on the structures reported for this protein (14–20),
it is not reasonable to propose a hydrodynamic diameter
of 1.1 nm for a monomeric state. We reproduced the DLS
experiments with AFP III between 0.5 and 22.1 mg mL1
under the same experimental conditions. The AFP III
solutions were homogeneous (with minor amounts of
very large particles interpreted as dust at the lowest
concentrations) with particles of RS ~ 1.3 nm correspond-
ing to the protein monomer. Thus, in the light of our
results, the largest particle observed by Liu and Du corre-
sponds to the monomer of type III AFP, and the smallest
(RS ~ 0.5 nm) may be a solvent component or artifact. It is
extremely difficult to perform DLS experiments on diluted
samples, and small-angle scattering is very sensitive to
large particles. The SANS experiments provided no
evidence for associated states of AFP III in solution, and
confirmed the presence of AFP III as a monomer in the
10–20 mg mL1 range. Furthermore, the SANS scattering
curves superimposed with that calculated from the AFP III
crystal structure emphasize that the solution structure is at
least grossly similar to that described from crystallography.
The SANS experiments were done at 6C in D2O, which
confirms that AFP III does not auto-associate at a tempera-
ture close to freezing (the melting point of D2O is 3.82
C).Does the studied recombinant protein behave
similarly to the native AFP III from ﬁsh plasma?
The ocean pout, M. americanus, produces a mixture of at
least 12 type III AFPs isoforms (42,43). Among these, the
HPLC-12 isoform studied here has been the most extensively
studied and was the first to have its three-dimensional struc-
ture solved (14). In earlier structural studies (14,16,44), the
HPLC-12 component (and also other isoforms) was pro-
duced by recombinant methods (45), and in the last 15 years
the recombinant protein has been used in all kinds of exper-
iments because no difference has been found between the
natural and recombinant HPLC-12 isoforms. There is no
consensus sequence for phosphorylation or glycosylation,
and, as far as we know, no evidence of a possible posttrans-
lational modification has been published. From E. coli, the
isoform HPLC-12 is obtained in inclusion bodies, which
are usually dissolved in urea 6 M or 8 M (46). For the solu-
bilization step, we used only 2 M of urea, which is enough to
solubilize the protein but not enough to perturb the native
structure (47). A pH value of 4 (used in the standard purifi-
cation protocol, independently of the source of the protein)
does not modify the protein properties, since AFP III is
active from pH 2 to pH 11 (46). The crystal structure was
solved at pH 4.0–4.5 (18,20,44), and indeed we were able
to obtain crystals from our preparation. The monomeric state
we observed here is also in agreement with the pioneer
studies that characterized AFP III (42,43). The first purifica-
tion step was at size-exclusion column Sephadex G-75,
which has a fractionation range for globular proteins of
3000–80,000 Da. (In their study, Hew et al. (42) reported
that ‘‘the chromatography of the ocean pout’s serum
produced only one peak of macromolecular ‘antifreeze’
activity having an apparent molecular weight of 10000’’.)Does the surface tension of AFP III differ
from other globular proteins?
Our study was motivated by publications describing the
formation of micelle-like structures for AFP III above
2.5 mg mL1, as determined by surface tension measure-
ments (25,27). Because we do not observe such assemblies
in solution, we chose to reinvestigate the behavior of AFP III
at the air/water interface. Although our first measurements
for AFP III only poorly reproduced the published results
(Fig. 4, stirring time of 5 min), our second measurements
with a longer equilibration time produced results more
similar to those of Du et al. (25), i.e., a minimum value
without plateau followed by an increase of surface tension
when AFP III concentration exceeded 2.3 mg mL1 (Fig. 4,
stirring time of 20 min). A break and a plateau would be
expected if the interface were saturated, which happens at
the critical micellar concentration for a surfactant. Proteins
are naturally amphiphilic, with a primary structure contain-
ing both hydrophobic and hydrophilic amino acid residues.Biophysical Journal 99(2) 609–618
616 Salvay et al.For proteins denatured in foam, an apparent critical micellar
concentration can be defined that represents the concentration
at which there is completemonolayer coverage at the interface
(48). A plateau is also observed for proteins that form struc-
tures similar to micelles in solution, such as b-casein
(49,50). It was previously hypothesized that AFP III forms
micelles (25), but we have demonstrated that in solution it is
monomeric and does not form aggregates up to 20 mg mL1.
Therefore, the surface activity ofAFP III is not correlatedwith
any aggregation of the protein in the bulk. Does the surface
tension of AFP III differ from that of other globular proteins?
A common feature in the few globular proteins that have been
documented to show changes in the surface tension with
concentration is a maximum decrease of ~20 mN m1. This
value has been described as being practically independent
of the type of protein (the tested proteins had molecular
masses between 15 and 150 kDa, whereas that of AFP III is
7 kDa) and the experimental conditions used, with a plateau
at low and/or high concentrations. The former is tentatively
explained by the formation of a close-packed adsorption
protein layer immersed in the aqueous subphase, and the latter
by the formation of an ordered, quasi-crystal protein mono-
layer at the interface (51,52). In our experiments (dilution
series), as well as in previous experiments with increasing
protein concentrations, AFP III displayed a surface tension
that did not exceed 53 mNm1, even at the lowest concentra-
tion (0.005 mg mL1). This suggests a propensity of AFP III
to be localized at the air/water interface, and we can hypoth-
esize that the variation with concentration of the surface
tension would reflect slight modifications in the packing of
AFP III at the interface.
Previously published surface tension and DLS experi-
ments, which were not correctly interpreted (as we demon-
strate here), led to the proposal that above a critical protein
concentration of 2.5 mg mL1, the amphipathic proteins
self-assemble to form micelle-like structures with a hydro-
phobic core and a hydrophilic surface, and suggested that
specific protein-protein interactions are required for cooper-
ative binding to ice (25–27). A self-assembly of AFP III on
the surface of ice, in a manner similar to that of emulsions of
oil in water with amphiphilic surfactants, was proposed
(25–27). We have demonstrated that no association of
AFP III monomers occurs in the bulk. This suggests that
each AFP III molecule acts independently of the others,
and that specific intermolecular interactions between mono-
mers may not be required before binding to ice occurs. Our
surface tension data, however, confirm the capacity of AFP
III to colocalize at the interface. Because of the influence
on the dipole moment of the macromolecule, protein surface
activity depends on details of the secondary structure (51),
and we can speculate that the unusual surface tension
behavior of AFP III may be related to its unusual structure,
as suggested by CD and Raman optical activity (53), and/
or to particular rearrangements of the protein at the surface.
Indeed, AFP III has been shown to be flexible (a two-domainBiophysical Journal 99(2) 609–618tandem structure, with two connected domains tumbling and
moving independently, was reported by NMR (54)). The low
value of the surface tension at low protein concentration may
be important for the efficiency of the protein functionality
observed at low concentrations (55).CONCLUSIONS
Currently, there is no general theory that can explain all the
activities of the so-called ‘‘antifreeze’’ proteins, i.e., inhibi-
tion of ice growth at millimolar concentrations, inhibition
of ice recrystallization at nanomolar concentrations, and
decreased damage during low-temperature preservation of
living cells at above-zero temperatures (2,13). These
phenomena are observed at different concentrations and
temperatures. However, these diverse and complex activities
have the same starting point: the protein in aqueous solution.
We confirm herein that AFP III is monomeric under a large
range of experimental conditions. Our results agree with
those obtained by DeLuca and co-workers (24), and support
the hypothesis that each AFP III molecule acts independently
and that specific intermolecular interactions between mono-
mers are not required for binding to ice. According to the
two-step adsorption and growth inhibition mechanism
proposed for AFP activity, the complete covering of ice by
AFPs is not required for antifreeze activity (6). The nonexis-
tence of attractive interactions between AFP III monomers,
as demonstrated here, may be functionally important for
more efficient binding and covering of the ice surface. This
effect may also be linked to the efficiency of the protein func-
tionality observed at low concentrations (55).SUPPORTING MATERIAL
Complementary information on chemical homogeneity of AFP III by gel
electrophoresis and mass spectrometry, ultraviolet spectroscopy, extinction
coefficient and circular dichroism of AFP III, determination of the partial
specific volume of AFP III, analytical ultracentrifugation (AUC), analytical
size-exclusion chromatography with light scattering detection, dynamic light
scattering, small-angle neutron scattering, and surface tension measurements
is available at http://www.biophysj.org/biophysj/supplemental/S0006-
3495(10)00528-X.
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